Search in:

Advanced search

Current Medical Research and Opinion Volume 27, 2011 - Issue 4

Submit an article Journal homepage

777

Views

CrossRef citations to date

Altmetric

Original Article

Efficacy and safety of saxagliptin in older patients with type 2 diabetes mellitus

Jean Doucet Rouen University Hospital, Rouen, FranceCorrespondence[email protected]

Antonio Chacra Federal University of São Paulo, São Paulo, Brazil

Pierre Maheux AstraZeneca Europe, Brussels, Belgium

Jane Lu AstraZeneca, Wilmington, DE, USA

Susan Harris AstraZeneca, Wilmington, DE, USA

Julio Rosenstock Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, USA

Pages 863-869 | Accepted 04 Jan 2011, Published online: 05 Apr 2011

Cite this article
https://doi.org/10.1185/03007995.2011.554532

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

References

Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2009;87:4-14
PubMed Web of Science ®Google Scholar
Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53
PubMed Web of Science ®Google Scholar
DECODE. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003;26:61-9
PubMed Web of Science ®Google Scholar
Fagot-Campagna A, Bourdel-Marchasson I, Simon D. Burden of diabetes in an aging population: prevalence, incidence, mortality, characteristics and quality of care. Diabetes Metab 2005;31:5S35-52
PubMed Web of Science ®Google Scholar
Bourdel-Marchasson I, Berrut G. Caring the elderly diabetic patient with respect to concepts of successful aging and frailty. Diabetes Metab 2005;31:5S13-19
PubMed Web of Science ®Google Scholar
Doucet J. Use of antidiabetic drugs in elderly patients. Diabetes Metab 2005;31:5S98-104
PubMed Web of Science ®Google Scholar
Abbatecola AM, Maggi S, Paolisso G. New approaches to treating type 2 diabetes mellitus in the elderly: role of incretin therapies. Drugs Aging 2008;25:913-25
PubMed Web of Science ®Google Scholar
Bourdel-Marchasson I, Doucet J, Bauduceau B, et al. Key priorities in managing glucose control in older people with diabetes. J Nutr Health Aging 2009;13:685-91
PubMed Web of Science ®Google Scholar
Doucet J, Druesne L, Capet C, et al. Risk factors and management of diabetes in elderly French patients. Diabetes Metab 2008;34:574-80
PubMed Web of Science ®Google Scholar
Chacra AR, Tan GH, Apanovitch A, et al. Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial. Int J Clin Pract 2009;63:1395-406
PubMed Web of Science ®Google Scholar
DeFronzo RA, Hissa MN, Garber AJ, et al. The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone. Diabetes Care 2009;32:1649-55
PubMed Web of Science ®Google Scholar
Hollander P, Li J, Allen E, et al. Saxagliptin added to a thiazolidinedione improves glycemic control in patients with type 2 diabetes and inadequate control on thiazolidinedione alone. J Clin Endocrinol Metab 2009;94:4810-19
PubMed Web of Science ®Google Scholar
Jadzinsky M, Pfutzner A, Paz-Pacheco E, et al. Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial. Diabetes Obes Metab 2009;11:611-22
PubMed Web of Science ®Google Scholar
Rosenstock J, Sankoh S, List JF. Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes. Diabetes Obes Metab 2008;10:376-86
PubMed Web of Science ®Google Scholar
Rosenstock J, Guilar-Salinas C, Klein E, et al. Effect of saxagliptin monotherapy in treatment-naive patients with type 2 diabetes. Curr Med Res Opin 2009;25:2401-11
PubMed Web of Science ®Google Scholar
Boulton DW, Goyal A, Li L, et al. The effects of age and gender on the single-dose pharmacokinetics and safety of saxagliptin in healthy subjects. Diabetes Care 2008;57(Suppl 1) Abstract 164
Google Scholar
Data on file. AstraZeneca/Bristol-Myers Squibb, CV181-038. 2009
Google Scholar
Pratley RE, Rosenstock J, Pi-Sunyer FX, et al. Management of type 2 diabetes in treatment-naive elderly patients: benefits and risks of vildagliptin monotherapy. Diabetes Care 2007;30:3017-22
PubMed Web of Science ®Google Scholar
Pratley RE, McCall T, Fleck PR, et al. Alogliptin use in elderly people: a pooled analysis from phase 2 and 3 studies. J Am Geriatr Soc 2009;57:2011-19
PubMed Web of Science ®Google Scholar
Schweizer A, Dejager S, Bosi E. Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24-week, double-blind, randomized trial. Diabetes Obes Metab 2009;11:804-12
PubMed Web of Science ®Google Scholar
Rosenstock J. Management of type 2 diabetes mellitus in the elderly: special considerations. Drugs Aging 2001;18:31-44
PubMed Web of Science ®Google Scholar
Dhillon S, Weber J. Saxagliptin. Drugs 2009;69:2103-14
PubMed Web of Science ®Google Scholar
Onglyza 5 mg film-coated tablets: summary of product characteristics [article online]. Available from http://emc.medicines.org.uk/medicine/22315/SPC/Onglyza. Accessed 23 July 2010
Google Scholar
Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12
PubMed Web of Science ®Google Scholar
Goh HK, Chia M, Ooi YW, et al. Silent myocardial infarction and hypoglycaemia: four case reports and a discussion on causality. The Endocrinologist 2010;20:2-6
Web of Science ®Google Scholar
Constans T. Plasma glucose goals and therapeutic management in elderly diabetic patients. Diabetes Metab 2005;31:5S58-61
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Efficacy and safety of saxagliptin in older patients with type 2 diabetes mellitus

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Efficacy and safety of saxagliptin in older patients with type 2 diabetes mellitus

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date